Jason E. Anderson - 22 Feb 2022 Form 4 Insider Report for ModivCare Inc (MODV)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
24 Feb 2022, 14:55:17 UTC
Prior SEC filing
10 Feb 2022
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Jonathan Bush by Power of Attorney

Key filing fact

Jason E. Anderson filed Form 4 for ModivCare Inc (MODV) on 24 Feb 2022.

Key facts

  • This page summarizes Jason E. Anderson's Form 4 filing for ModivCare Inc (MODV).
  • 3 reported transactions and 2 derivative rows are listed below.
  • Accepted by SEC: 24 Feb 2022, 14:55.

Change

  • Previous filing in this sequence was filed on 10 Feb 2022.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

MODV transaction

Common Stock

Award

Transaction value
$0
Shares
+903
Change %
+80%
Price
$0.000000
Shares after
2,038
Date
22 Feb 2022
Ownership
Direct
Footnotes
F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

MODV transaction Derivative

Employee Stock Option (Right to Buy)

Award

Transaction value
$0
Shares
+2,743
Change %
Price
$0.000000
Shares after
2,743
Date
22 Feb 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
$2,743
Exercise price
$101.51
Footnotes
F2
MODV transaction Derivative

Performance Restricted Stock Units

Award

Transaction value
$0
Shares
+1,807
Change %
Price
$0.000000
Shares after
1,807
Date
22 Feb 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Exercise price
Footnotes
F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Represents restricted stock units scheduled to vest as follows: (1) 301 shares will vest on February 22, 2023, (2) 301 shares will vest on February 22, 2024 and (3) 301 shares will vest on February 22, 2025, in each case, subject to the reporting person's continued employment.

Footnote F2

Option becomes exercisable with respect to: (1) 914 shares on February 22, 2023, (2) 915 shares on February 22, 2024 and (3) 914 shares on February 22, 2025, in each case, subject to the reporting person's continued employment.

Footnote F3

Represents the contingent right to receive a number of shares of issuer common stock determined by multiplying the number of performance units awarded by a percentage from 50% to 200% that corresponds to the highest specified target value-weighted average price (VWAP) per share of common stock of the issuer over a specified period of consecutive trading days achieved prior to the expiration date of the award, subject to the reporting person's continued employment.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .